Form 4: Wave Life Sciences Director Sells Shares
Insider Transaction (Form 4)
Adrian Rawcliffe, a Director of Wave Life Sciences Ltd., sold 12,700 shares of common stock on August 12, 2026 for $5.29 per share.
Summary
- Open-market sale: disposed of 12,700 Common Stock at $5.29 ($67,183) on August 12, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $67,183 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Adrian Rawcliffe — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Open-market sale | Common Stock | 12,700 | $5 | $67.2K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Open-market sale (12,700 shares) |
Keywords
insider transaction, Form 4, WVE, Wave Life Sciences, Inc., bearish, Adrian Rawcliffe
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.